3
Total investments
0
Early stage
0
Mid stage
0
Late stage
5y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Nov 2025
Ajinomoto Group Ventures is the corporate venture capital arm of Ajinomoto, a $10B revenue technology leader in amino science.
We invest in transformative companies that advance new ways to extend health span, develop new approaches that change the ways information is processed, and answer complex challenges in sustainability.
Together with Ajinomoto’s community of scientists and engineers, we enable startup founders to build and scale solutions for the future.
Consultant | Neuroinflammation Investments
Aug 2021
UPMC Enterprises is the commercialization arm of UPMC, a Pittsburgh-based health care provider and insurer. At UPMC Enterprises, we believe that the smart integration of technology will be critical to solving the complex problems facing the health care industry.
As an organization dedicated to Life Changing Medicine, UPMC has defined a bold mission: to shape the future of health care through innovation. At UPMC Enterprises, we help bring this mission to life by turning innovative ideas into growing, thriving businesses. Through pioneering technology, we seek to improve the quality and reduce the cost of health care while continuously enhancing the overall patient experience.
At UPMC Enterprises, we both develop and invest in exceptional health care technology. Not only are we seeking to reinvent how consumers engage with the health care industry, but also how to use clinical tools to reinvent care delivery, and how to interpret data to manage risk and address new revenue models. If you have a passion for innovation and a desire to transform health care, we invite you to learn more about career opportunities available at UPMC Enterprises.
Experience · 5 entries
All (5)
Investments (3)
2025
Investor
Nov 2025
Ajinomoto Group Ventures is the corporate venture capital arm of Ajinomoto, a $10B revenue technology leader in amino science.
We invest in transformative companies that advance new ways to extend health span, develop new approaches that change the ways information is processed, and answer complex challenges in sustainability.
Together with Ajinomoto’s community of scientists and engineers, we enable startup founders to build and scale solutions for the future.
2024
Venture Partner, Entrepreneur in Residence (HealthTech)
Aug 2024
“A problem well stated is a problem half-solved, while a problem not well-stated is unsolvable.” – Charles Kettering, Head of Research at General Motors 1920-1947
For decades, academics and venture builders have assumed that the <1% success rate we see from market creating ventures was the unavoidable nature of the challenge. They believed it was the natural consequence of high uncertainty.
However, in the words of the late Clayton Christensen, “... when the business world encounters an intractable management problem, it’s a sign that business executives and scholars are getting something wrong–that there isn’t yet a satisfactory theory for what’s causing the problem, and under what circumstances it can be overcome.”
Half-Solved’s founder, Dr Erik Simanis, has dedicated his career to solving this problem. In partnership with entrepreneurs, investors, corporate venture teams, and researchers, he has spent two decades researching the causes of market creation’s high failure rate, and developing the tools needed to overcome them.
Half-Solved are experts in market creation.
They use Integrative Venture Engineering, the world’s first methodology for profitably and reliably creating new markets, to build market creating ventures and help others to do the same.
Alongside Cornell University and the International Council on Systems Engineering (INCOSE), Half-Solved are founding partners in the Market Creators Lab, a membership-based organisation dedicated to advancing and disseminating Integrative Venture Engineering.
2022
Venture Capital | Biomedical & Digital Health
Feb 2022
Integrated is a venture fund partnering with value-aligned companies and entrepreneurs that are transforming the health and well-being of our communities around the globe.
2021
Consultant | Neuroinflammation Investments
Aug 2021
UPMC Enterprises is the commercialization arm of UPMC, a Pittsburgh-based health care provider and insurer. At UPMC Enterprises, we believe that the smart integration of technology will be critical to solving the complex problems facing the health care industry.
As an organization dedicated to Life Changing Medicine, UPMC has defined a bold mission: to shape the future of health care through innovation. At UPMC Enterprises, we help bring this mission to life by turning innovative ideas into growing, thriving businesses. Through pioneering technology, we seek to improve the quality and reduce the cost of health care while continuously enhancing the overall patient experience.
At UPMC Enterprises, we both develop and invest in exceptional health care technology. Not only are we seeking to reinvent how consumers engage with the health care industry, but also how to use clinical tools to reinvent care delivery, and how to interpret data to manage risk and address new revenue models. If you have a passion for innovation and a desire to transform health care, we invite you to learn more about career opportunities available at UPMC Enterprises.
Investment activity
2021–2025 · 3 investments
Recent (last 2 years)Earlier
